The Brattleboro rat carries as a recessive trait the inability to synthesize hypothalamic vasopressin and its related neurophysin but is able to synthesize oxytocin and its neurophysin. Brattleboro rats homozygous for this trait have no immunologically detectable circulating vasopressin and manifest a complete syndrome of diabetes insipidus, which is corrected with vasopressin replacement therapy. Such a defect could be due to absence of the gene encoding vasopressin, the presence of an abnormal gene, or a variety of transcriptional or posttranscriptional abnormalities. We report here that the hypothalamus of the Brattleboro rat contains detectable, although markedly reduced, levels of an mRNA indistinguishable in size with and similar in sequence to authentic vasopressin mRNA. Corresponding levels of oxytocin mRNA were the same in Brattleboro and normal rat hypothalami. These findings indicate that the Brattleboro rat expresses a vasopressin gene, but at a reduced level.
the presence of an abnormal gene, or a variety of transcriptional or posttranscriptional abnormalities. We report here that the hypothalamus of the Brattleboro rat contains detectable, although markedly reduced, levels of an mRNA indistinguishable in size with and similar in sequence to authentic vasopressin mRNA. Corresponding levels of oxytocin mRNA were the same in Brattleboro and normal rat hypothalami. These findings indicate that the Brattleboro rat expresses a vasopressin gene, but at a reduced level.
Vasopressin (VP) and oxytocin (OT), nonapeptides synthesized in the magnocellular neurons of the hypothalamus, are secreted via axons in the neurohypophysis and regulate water conservation, cardiovascular functions, and smooth muscle contractions (1) . Both peptides are synthesized as precursors in covalent linkages with neurophysin peptides, termed preproVP-neurophysin and preproOT-neurophysin (2) (3) (4) . The Brattleboro rat carries as a semirecessive trait the inability to synthesize VP or its related neurophysin but is able to synthesize OT and its neurophysin (5) . Brattleboro rats homozygous for this trait have severe diabetes insipidus, which is completely corrected by VP replacement therapy. Although the Brattleboro rat has been used extensively in the study of VP deficiency, nothing is known regarding the nature of its genetic defect. Therefore, we examined this issue using molecular biological techniques. Such studies might shed some light on the nature of the analogous genetic defect in hereditary human VP deficiency. Our findings indicate that the Brattleboro rat does possess the gene for VP and expresses this gene, although at a markedly reduced level.
MATERIALS AND METHODS
Preparation and 5'-End Labeling of Synthetic Oligonucleotides. Oligonucleotides were synthesized by the triester method and were purified by reversed-phase high-pressure liquid chromatography on C18 resin (Waters Associates) (6).
For use in subsequent studies, the oligonucleotides were 5'-end-labeled using [y32P]ATP (Amersham) and T4 polynucleotide kinase (Bethesda Research Laboratories) to a final specific activity of 4-6 x 106 cpm/pmol (7) . Nucleotide sequences of the oligonucleotides were confirmed using the chemical degradation method (8) .
Preparation of Hypothalamic mRNA. Adult female (180-200 gm) homozygous Brattleboro rats were deprived of water for 24 hr prior to decapitation. They were confirmed to be homozygous for the Brattleboro trait by two criteria: (i) they all lost >20% of their body weight after 24 hr of water deprivation, compared with <5% loss in Long-Evans rats and (ii) by radioimmunoassay. Plasma VP was undetectable (<2 pg/ml) after 24 hr of water deprivation, compared to >8 pg/ml in Long-Evans rats (data not shown). Adult female (200-225 gm) Long-Evans rats were given 2% saline to drink for 1 wk prior to decapitation. Total hypothalamic nucleic acids were prepared by using guanidinium thiocyanate, total cellular RNA was isolated by differential centrifugation in cesium chloride, and polyadenylylated mRNA was isolated by affinity chromatography on oligo(dT)-cellulose (T-3, Collaborative Research, Waltham, MA) (9, 10) .
RNA Blot Hybridization Analysis of Hypothalamic mRNAs.
RNA (5 tug) was denatured in 1 M glyoxal/50% percent dimethyl sulfoxide, electrophoresed through a 1.5% agarose gel, transferred to nitrocellulose in 20x NaCl/Cit (1 x NaCl/ Cit is 0.15 M NaCl/0.015 M sodium citrate, pH 7.4), and baked (4, 11) . Each filter was 6pretreated, hybridized to 32P-labeled pentadecamer (1 x 10 cpm/ml), and washed as described (4). Autoradiography was performed for 24-48 hr at -70°C using an enhancing screen. Reverse Transcription, Polyacrylamide Gel Electrophoresis, and Nucleotide Sequence Analysis of Hypothalamic cDNAs. For analytical purposes, 1 ,g of mRNA and 2 pmol of 32P-end-labeled oligonucleotide in 100 mM KCl/0.1 mM EDTA/100 mM Tris-HCl, pH 8.3, were hybridized at 4°C for 2 hr, after which reverse transcription was carried out as described (4), followed by extraction with phenol/chloroform, precipitation in ethanol, digestion in alkali, and denaturation in 5 M urea (12) . For preparative purposes, the reactions were scaled up by a factor of 10 (Long-Evans rats) or 20 (Brattleboro rats). The cDNAs were subjected to electrophoresis in 5% denaturing polyacrylamide gels containing 7 M urea (13) . Autoradiography was carried out at -70°C with an enhancing screen (Lightning Plus, DuPont). Relevant cDNAs were eluted from the gel (14) , and their sequences were determined (8) .
RESULTS
To determine the relative levels of preproVP-neurophysin and preproOT-neurophysin mRNAs in the hypothalamus of homozygous Brattleboro and normal syngeneic Long-Evans rats, we used 32P-labeled synthetic oligonucleotides complementary to the mRNAs in both filter hybridization assays (blot hybridizations) of the hypothalamic mRNAs and as primers to synthesize labeled cDNAs from the mRNA tem- 
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plates. Initially, we synthesized an undecanucleotide, VP/ OT-11, complementary to the portion of the mRNA encoding the fourth through seventh amino acids of both VP and OT and subsequently synthesized a mixed pentadecanucleotide, VP/OT-15, complementary to the portions of mRNA encoding the first five amino acids of VP and OT (Fig. 1) . The two pentadecamers in the mixture were largely separated one from the other by high-pressure liquid chromatography: (4) . The undecamer and pentadecamers have in common a sequence of six nucleotides but otherwise are complementary to different regions of VP and OT mRNAs (Fig. 1) . RNA blot hybridization analysis of Long-Evans and Brattleboro rat hypothalamic mRNAs was not possible with labeled VP/OT-11 because of inefficient hybridization of this oligonucleotide to the membrane filter at conditions of stringency that avoided a severe background of nonspecific radioactivity on the membrane. However, the oligonucleotide OT-15 hybridized strongly to the OT-neurophysin mRNA isolated from the hypothalami of both LongEvans and Brattleboro rats and to a slight extent to VP-neurophysin mRNA of Long-Evans but not of Brattleboro rats (Fig. 2B) . In contrast, when VP-15 was used for hybridization to the hypothalamic mRNAs, it detected predominantly the VP-neurophysin mRNA, including a small amount of this mRNA in the hypothalamus of the Brattleboro rat ( Fig. 2A) .
Although these data suggested that the VP-neurophysin gene is expressed at low levels in the Brattleboro rat, it was possible that Brattleboro VP-neurophysin mRNA might be expressed at the same level as is found in the Long-Evans rat but might contain one or more point mutations in the region complementary to the synthetic oligonucleotides used in this study, permitting only weak hybridization between the mRNA and oligonucleotides. Therefore, we synthesized an oligonucleotide of Fig. 2C ) was detected in the Brattleboro hypothalamic mRNA compared to a strong band in the Long-Evans mRNA (Fig. 2C) To further investigate the structure of VP-neurophysin mRNA in the hypothalamus of the Brattleboro rat, reverse transcription reactions were performed with Brattleboro and Long-Evans rat hypothalamic mRNAs primed with either the undecamer VP/OT-11 or the mixed pentadecamer VP/OT-15 (Fig. 3) . Both oligonucleotides reverse transcribed three cDNAs of -150 bases in length from the LongEvans mRNA templates (Fig. 3, lanes a and c) . We reported previously that the larger two cDNAs are identical in nucleotide sequence and correspond to the 5' end of VP-neurophysin mRNA, whereas the fastest migrating cDNA is complementary to the 5' end of OT-neurophysin mRNA (4 
FIG. 4. Nucleotide sequence comparison of preproVP-neurophysin mRNA in Long-Evans (upper nucleotide line) and Brattleboro Rats (lower line). In the upper line, the boxed area indicates VP; amino acids in italics were derived from the known amino acid sequence of VP. In the lower nucleotide line, dashes denote areas where nucleotide sequence could not be definitely assigned. Vertical lines denote nucleotide sequence homology between the two strains of rats. The arrow denotes the region of hybridization of VP/OT-11; VP-21 hybridized to VPneurophysin mRNA in the region of codon -19 to codon -13. differences in the sizes of the cDNAs primed with VP/OT-11 and VP/OT-15 are due to the different regions of VP and OT mRNAs to which the oligonucleotides hybridize (Fig. 1) .
The oligonucleotides VP/OT-11 and VP/OT-15 were next used to prime cDNA synthesis using hypothalamic mRNA isolated from Brattleboro rats (Fig. 3, lanes b and d) . Brattleboro hypothalamic mRNA contained normal levels of cDNAs corresponding to OT-neurophysin mRNA as compared with that found in Long-Evans hypothalamic mRNA. The nucleotide sequences of these cDNAs were identical to those of the OT-neurophysin cDNA primed from LongEvans hypothalamic mRNA (4) . When the oligonucleotides VP/OT-15 and VP/OT-11 were used to prime the synthesis of cDNAs from hypothalamic mRNA isolated from Brattleboro rats, the cDNAs corresponding to VP-neurophysin mRNA were notably diminished, particularly when VP/OT-15 was used, compared to the corresponding cDNAs prepared from the hypothalami of the Long-Evans rats (Fig. 3,  lanes b and d) . Based upon the known specific activity of VP/OT-11 (5 x 106 cpm/pmol) and the amount of radioactivity present in Long-Evans and Brattleboro VP-neurophysin cDNA (18,000 and 4,000 cpm, respectively), it is estimated that VP-neurophysin mRNA accounts for 0.01% of total poly(A)+ mRNA in the Long-Evans rat and for 0.001% of total poly(A)+ mRNA in the Brattleboro rat.
The cDNAs corresponding in size to VP-neurophysin cDNA primed using Long-Evans hypothalamic mRNA were isolated and sequenced. Notable was the finding that the nucleotide sequence of the cDNA resulting from the priming of Brattleboro hypothalamic mRNA with VP/OT-11 was complementary to Long-Evans VP-neurophysin mRNA in the regions in which the sequence could be determined, demonstrating that the hypothalamus of the Brattleboro rat indeed contains mRNA encoding VP, although in markedly reduced amounts compared to that in the hypothalamus of the LongEvans rat (Fig. 4) .
DISCUSSION
These data show that the Brattleboro rat does possess the gene for VP and that this gene is expressed in RNA, albeit at low levels compared to that in the Long-Evans rat. This reduced expression of the VP gene could be due to decreased transcription of a structurally normal gene as a consequence of either a genetic lesion proximal to the transcription process, such as a defect in the osmotic sensing apparatus of the magnocellular neuron, or a gene defect in the promoter, analogous to that found in /-thalassemia (15) . Alternatively, transcription could proceed at a normal rate but result in an abnormal mRNA or mRNA precursor because of an abnormality either in primary nucleotide sequence, such as deletion (16), insertion (17) or conversion (18) , or an abnormality in the processing of the pre-mRNA (15, 19) . A large insertion, deletion, or defect in mRNA processing in the transcribed region of the gene is not likely given the similar sizes of VP-neurophysin mRNA in Long-Evans and Brattleboro rats, as determined both by RNA blot hybridization and primer extension experiments. In support of this, Schmale et al. (20) have stated that by Southern blot analysis, the VP genes of Brattleboro and Long-Evans rats are indistinguishable. Any of these defects could result in an unstable mRNA that is rapidly degraded, resulting in low steady-state levels of VP-neurophysin mRNA in the hypothalamus of the Brattleboro rat. Transcriptional (polymerase) run-off experiments (21) may help to address this issue.
Despite its shorter length, oligonucleotide VP/OT-11 primed a VP-neurophysin-related cDNA more efficiently than did VP/OT-15. This circumstance suggests the possibility of decreased hybridization between VP/OT-15 and Brattleboro VP-neurophysin mRNA in the region not spanned by VP/OT-11 (codons +1 to +3). Unfortunately, nucleotide sequence analysis of the Brattleboro VP-neurophysin cDNA in this region was not possible, and resolution of this discrepancy must await nucleotide sequence analysis of a Brattleboro VP-neurophysin cDNA or gene.
Although most studies have failed to show any immunologically detectable VP or VP-neurophysin in the hypothalamus or blood of the Brattleboro rat, two studies have demonstrated low levels of a VP-like material in the Brattleboro hypothalamus (22, 23) , raising the possibility that Brattleboro VP-neurophysin mRNA is translated into a protein. A definitive answer to this question awaits the determination of the complete nucleotide sequence of the Brattleboro VPneurophysin gene, chemical synthesis of the corresponding Brattleboro VP-neurophysin precursor protein, production of antisera to this protein, and the use of such antisera to search for VP-neurophysin in the Brattleboro rat.
Note Added in Proof. Since submission of this manuscript, Schmale and Richter (24) have reported the sequence of a preproVP-neurophysin gene obtained from the Brattleboro rat. The gene lacks a single guanosine residue in the protein-coding region, giving rise to an open reading frame and predicting a hormone precursor having a different COOH terminus. Whether or not this is the controlling defect remains to be determined (25) .
